PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

Takeo Fujita(National Cancer Center Hospital East), Nobutaka Shimizu(Kochi Medical School Hospital)

British Journal of Cancer

January 1, 2006

10.1038/sj.bjc.6602926

Cited by 156

Related Papers

No related papers found

Powered by citation graph analysis